Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127002461 | 12700246 | 1 | I | 20160818 | 20160830 | 20160830 | PER | US-MEDA-2016080088 | MEDA | THOMAS, PHARM.D, PH.D K,WILKINS, PH.D, M.S D,CURRY, M.D S,GREY, M.D T,ANDRENYAK, PH.D D,MCGILL, D.V.M, PH.D L,ROLLINS, M.D, PH.D D. DETECTION OF ACETAMINOPHEN-PROTEIN ADDUCTS IN DECEDENTS WITH SUSPECTED OPIOID-ACETAMINOPHEN COMBINATION PRODUCT OVERDOSE. JOURNAL OF FORENSIC SCIENCES 2016; 1-6 | 43.00 | YR | A | F | Y | 0.00000 | 20160830 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127002461 | 12700246 | 1 | PS | CARISOPRODOL. | CARISOPRODOL | 1 | 11792 | ||||||||||||
| 127002461 | 12700246 | 2 | SS | MORPHINE | MORPHINE | 1 | 0 | ||||||||||||
| 127002461 | 12700246 | 3 | SS | ALPRAZOLAM. | ALPRAZOLAM | 1 | 0 | ||||||||||||
| 127002461 | 12700246 | 4 | SS | HYDROCODONE | HYDROCODONE | 1 | 0 | ||||||||||||
| 127002461 | 12700246 | 5 | SS | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | 0 |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127002461 | 12700246 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127002461 | 12700246 | Toxicity to various agents |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |